AI Portfolio Summary
In 2025 Q4, Patient Square Capital LP maintained a portfolio of 33 distinct positions. The most significant new addition to the portfolio was BEONE MEDICINES LTD, which now represents 4.51% of the total fund value. They heavily accumulated shares in MIRUM PHARMACEUTICAL, increasing their position by 186.5%. Conversely, Patient Square Capital LP completely exited their position in CIDARA THERAPEUTICS .
Total Positions
33
Quarter
2025 Q4
Top Holding
ROIV (37.9%)
Top 10 Concentration
77.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 33
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 37.93% | 50.51% |
#1
Prev: #1
|
10.0 | -4,313,953 | -34.6% |
P
S
|
8,166,047 | $177,203,220 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 9.95% | 12.57% |
#2
Prev: #2
|
4.0 | -59,400 | -18.2% |
P
S
|
267,000 | $46,468,680 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 5.05% | 2.04% |
#3
7
Prev: #10
|
4.3 | 194,420 | 186.5% |
P
S
|
298,682 | $23,592,891 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 4.68% | 3.06% |
#4
2
Prev: #6
|
4.1 | 10,500 | 67.7% |
P
S
|
26,000 | $21,864,700 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 4.51% | — |
#5
Prev: #—
|
3.8 | 69,312 | no change |
NEW
|
69,312 | $21,057,679 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 3.75% | 3.45% |
#6
2
Prev: #4
|
1.5 | -21,833 | -14.4% |
P
S
|
130,000 | $17,530,500 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 3.22% | 2.30% |
#7
1
Prev: #8
|
3.5 | 197,315 | 57.1% |
P
S
|
542,696 | $15,059,814 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 3.05% | 3.85% |
#8
5
Prev: #3
|
1.3 | -231,839 | -22.9% |
P
S
|
780,000 | $14,250,600 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 2.77% | — |
#9
Prev: #—
|
3.1 | 320,000 | no change |
NEW
|
320,000 | $12,928,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 2.56% | 1.32% |
#10
4
Prev: #14
|
3.1 | 20,000 | 20.0% |
P
S
|
120,000 | $11,968,800 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.41% | — |
#11
Prev: #—
|
3.0 | 317,372 | no change |
NEW
|
317,372 | $11,273,053 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 2.32% | 1.40% |
#12
Prev: #12
|
3.1 | 46,408 | 50.1% |
P
S
|
139,000 | $10,815,590 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 1.68% | 2.43% |
#13
6
Prev: #7
|
0.8 | -173,000 | -43.2% |
P
S
|
227,000 | $7,829,230 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 1.47% | — |
#14
Prev: #—
|
2.6 | 359,050 | no change |
NEW
|
359,050 | $6,882,989 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 1.46% | 0.99% |
#15
5
Prev: #20
|
2.8 | 1,982,360 | 66.5% |
P
S
|
4,963,756 | $6,800,346 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.32% | 1.32% |
#16
1
Prev: #15
|
2.6 | 25,000 | 20.0% |
P
S
|
150,000 | $6,181,500 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.31% | — |
#17
Prev: #—
|
2.5 | 136,500 | no change |
NEW
|
136,500 | $6,117,930 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARQT
ARCUTIS BIOTHER...
|
Healthcare | 1.31% | — |
#18
Prev: #—
|
2.5 | 210,000 | no change |
NEW
|
210,000 | $6,098,400 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.27% | 2.24% |
#19
10
Prev: #9
|
0.6 | -225,000 | -31.5% |
P
S
|
490,000 | $5,948,600 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.26% | 1.31% |
#20
4
Prev: #16
|
0.5 | no change | no change |
P
S
|
74,000 | $5,876,340 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.21% | 0.34% |
#21
1
Prev: #22
|
2.8 | 211,966 | 212.0% |
P
S
|
311,966 | $5,665,303 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.05% | — |
#22
Prev: #—
|
2.4 | 150,000 | no change |
NEW
|
150,000 | $4,914,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.02% | 1.37% |
#23
10
Prev: #13
|
2.5 | 57,303 | 22.8% |
P
S
|
308,141 | $4,745,371 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 0.92% | 0.93% |
#24
3
Prev: #21
|
0.4 | -8,182 | -6.1% |
P
S
|
127,000 | $4,319,270 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.91% | 1.15% |
#25
7
Prev: #18
|
2.4 | 33,688 | 10.7% |
P
S
|
350,000 | $4,228,000 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.00% | 3.10% |
Sold All 😨
(Was: #5) |
0.3 | -121,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 0.00% | 1.44% |
Sold All 😨
(Was: #11) |
0.3 | -133,827 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
QURE
UNIQURE NV
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #17) |
0.3 | -75,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.00% | 1.08% |
Sold All 😨
(Was: #19) |
0.3 | -437,237 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GERN
GERON CORP
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #24) |
0.3 | -845,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 33 holdings